Back

Concomitant antiplatelet therapy in anticoagulated TAVI patients with atrial fibrillation: impact of sex on bleeding and ischaemic events in ENVISAGE-TAVI AF

29 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Risk and benefits of antithrombotic drugs Anticoagulants ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor George Dangas

Mount Sinai Medical Center, New York (United States of America)

5 More presentations in this session

Presentation thumbnail
Non-vitamin K antagonist oral anticoagulants versus warfarin and the risk of cataract in patients with atrial fibrillation: A real-world cohort study
Doctor S. Lin (Hualien, TW)
Abstract Slides
Presentation thumbnail
External validation of novel bleeding risk scores, ARC-HBR and PRECISE-HBR, in 5116 consecutive ACS patients in clinical practice
Professor A. Khand (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Prognostic impact of post-procedural low-molecular-weight heparin in high-bleeding risk patients undergoing pci for acute myocardial infarction
Doctor S. Qin (Tianjin, CN)
Abstract Slides
Presentation thumbnail
Impact of recurrent venous thromboembolism and major bleeding events on subsequent mortality in patients with and without active cancer: Insights from the COMMAND VTE Registry-2
Doctor S. Kobayashi (Tsu, JP)
Abstract Slides
Presentation thumbnail
Single versus dual antiplatelet therapy after transcatheter aortic valve implantation in patients without an indication for anticoagulation: a systematic review and meta-analysis
Doctor C. Sanchez Serrano (Ciudad De Mexico, MX)
Abstract Slides

Access the full session

Session thumbnail
Risk and benefits of antithrombotic drugs

The Event

Event poster

ESC Congress 2026

29 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between sex and transcatheter aortic valve replacement outcome for bicuspid and tricuspid aortic stenosis
1 September 2025
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025
thumbnail
Congress Presentation
Meta-analysis comparing impact of age, sex and renal function on the efficacy and safety of new oral anticoagulants vs. vitamin K antagonists for the treatment of acute venous thromboembolisms
28 August 2020
thumbnail
Congress Presentation
The new CHA2DS2-VA score: is female sex still a risk factor or not?
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources